Billiontoone (NASDAQ:BLLN) Reaches New 52-Week Low – Should You Sell?

Billiontoone, Inc. (NASDAQ:BLLN)’s stock price reached a new 52-week low on Monday . The company traded as low as $78.28 and last traded at $78.28, with a volume of 89205 shares changing hands. The stock had previously closed at $85.42.

Analyst Ratings Changes

A number of brokerages recently issued reports on BLLN. BTIG Research restated a “buy” rating and set a $160.00 target price on shares of Billiontoone in a research report on Wednesday, December 10th. Stifel Nicolaus began coverage on Billiontoone in a research note on Monday, December 1st. They set a “buy” rating and a $145.00 price target on the stock. Zacks Research raised Billiontoone to a “hold” rating in a research report on Tuesday, December 2nd. William Blair initiated coverage on Billiontoone in a research note on Monday, December 1st. They issued an “outperform” rating for the company. Finally, Wells Fargo & Company initiated coverage on Billiontoone in a research report on Monday, December 1st. They set an “equal weight” rating and a $110.00 target price on the stock. Six analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $135.29.

Billiontoone Trading Down 0.8%

The stock’s fifty day moving average is $87.70.

Billiontoone (NASDAQ:BLLN) last issued its earnings results on Tuesday, December 9th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.06). The firm had revenue of $83.52 million for the quarter, compared to analyst estimates of $82.86 million.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Seven Grand Managers LLC purchased a new stake in shares of Billiontoone during the 4th quarter valued at about $2,046,000. Capital International Investors acquired a new stake in Billiontoone in the fourth quarter valued at approximately $14,568,000. Adams Street Partners LLC purchased a new stake in shares of Billiontoone during the fourth quarter valued at approximately $140,063,000. Next Century Growth Investors LLC acquired a new position in shares of Billiontoone during the fourth quarter worth $3,000,000. Finally, MYDA Advisors LLC purchased a new position in shares of Billiontoone in the fourth quarter valued at $3,290,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.